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Background: Detection of psychiatric disorder in primary care is a complex issue. 
Distinctions between ‘normal’ emotional distress and psychiatric disorder depend on how 
disorder is conceptualised. Our aim was to explore two different conceptualisations by 
examining patients’ scores on one-dimensional depression measures and scores on the Four 
Dimensional Symptom Questionnaire (4DSQ), a measure that uniquely has separate 
dimensions for general distress and depressive disorder.  
 
Methods: This was a cross sectional study of 487 primary care patients attending general 
clinics in Hampshire, UK. Patients completed the 4DSQ, Patient Health Questionnaire-9 
(PHQ-9), General Health Questionnaire-12 (GHQ-12) and the Hospital Anxiety and 
Depression Scale (HADS) whilst in the waiting room. 
Results: The 4DSQ classified 26% (126/485) of patients as having heightened distress levels 
and 8% (38/468) as possible cases of depressive disorder.  Casesness was consistently higher 
across the one-dimensional measures (PHQ-9: 16%, GHQ-12: 28%, HADS-D: 13%). Of 
those patients deemed possible cases by the PHQ-9 (≥10), the 4DSQ classified 91% (71/78) 
as having heightened distress and 44% (32/72) as possible cases of depressive disorder.  
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Limitations: The sample was predominately older and white, which may limit generalisability 
of the findings to more diverse patient groups. There are limits to self-report measures in the 
assessment of complex diagnostic issues. 
Conclusions: Inclusion of a distinct general distress dimension alongside a dimension 
focusing on specific depression symptomatology lowered the number of primary care patients 
classified as possible cases of disorder. This view of symptoms may have implications for the 
targeting of existing treatments, and may be useful in guiding the development of novel self-
management interventions.  
Keywords: Distress; depression; primary care; assessment 
 
General Practitioners’ (GPs’) detection of psychiatric disorder has come under scrutiny 
(Nuyen et al., 2005) with suggestions that GPs miss around half (52%) of patients with 
depressive disorder (Mitchell et al., 2009). The proposed need to increase detection and 
treatment of disorders (Hickie, 2007; McQuaid et al., 1999) runs directly counter to the 
frequently voiced message that psychological symptoms are too often medicalised and may 
be overtreated (Dowrick, 2013; Mulder, 2008). These opposing positions add to the 
complexity GPs face when patients consult with psychological symptoms. Determining when 
patients present with symptoms reflecting ‘normal’ distress, and when they show signs 
suggesting underlying disorder is a difficult process (Hyde et al., 2005). Nonetheless, it is 
important in providing appropriate care, improving the targeting of interventions and 
reducing the provision of treatments that may inadvertently lead to harm (Fergusson et al., 
2005). 
Distinguishing distress from disorder 
The Diagnostic and Statistical Manual of the American Psychiatric Association (DSM) 
(American Psychiatric Association, 2000) provides the widely accepted consensus on what 
constitutes mental disorder. These definitions feed into primary care, both through GPs’ 
education and recommendations for practice (Moore et al., 2012). The Patient Health 
Questionnaire-9 (Kroenke et al., 2001), part of the larger PRIME-MD set (Spitzer et al., 
1999), is closely based on the DSM-IV criteria for major depressive disorder and is often 
recommended for determining the presence of depression in patients (Kendrick et al., 2009). 
Although as a self-report questionnaire it should be used as indicator of possible disorder, it is 
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often used as a diagnostic tool. Indeed, Kroenke et al.’s key paper states: “Brevity coupled 
with its construct and criterion validity makes the PHQ-9 an attractive, dual-purpose 
instrument for making diagnoses and assessing the severity of depressive disorders” p.612 
(Kroenke et al., 2001). A primary issue of concern with this shorthand way of defining 
depressive disorder is that it removes a critical element from the previous DSM editions that 
also features in the renewed DSM-5 (American Psychiatric Association, 2013). The DSM-5 
states: “An expectable or culturally approved response to a common stressor or loss such as 
the death of a loved one is not a mental disorder.” [emphasis added] p.20. Thus, to apply the 
DSM-5 definition correctly to distinguish and determine the presence of psychiatric disorder 
in practice, and to treat accordingly, the context in which the symptoms are occurring must be 
taken into account.  
 
The idea of a distinction between emotional distress and psychiatric disorder deviates from 
the commonly used continuum conceptualisation of depressive disorder, where presence of 
disorder is based primarily on functioning and symptom severity (Parker, 2000; Taylor & 
Fink, 2008). Nonetheless, it is consistent with the DSM-5 criteria for Major Depressive 
Disorder (MDD), which highlights the importance of distinguishing depressive disorder from 
loss reactions, and that determining between them “inevitably requires the exercise of clinical 
judgment based on the individual's history and the cultural norms for the expression of 
distress in the context of loss” p.161 (American Psychiatric Association, 2013). Within the 
debates regarding how best to define psychiatric disorder, Jerome Wakefield continues to 
make a strong case for the importance of a distinction (Horwitz and Wakefield, 2007). 
Wakefield proposes that psychiatric disorder should be set apart from non-disordered distress 
reactions, and reserved for the ‘harmful dysfunction’ of an internal system (Wakefield, 2007), 
biological, affective or cognitive. The harmful dysfunction conceptualisation allows the 
possibility of severe (often functionally disabling) distress that is not being driven by a 
disordering internal system. Rather, the distress experienced may be an appropriate response 
to environmental/social stressors. For example, according to control theory (Carver and 
Scheier, 1982) negative affect plays a key role in guiding human behavior by providing 
feedback into control-systems that encourage the disengagement from particular non-
rewarding or punishing goals (Carver et al., 1996; Carver and Scheier, 1990). Importantly, 
Wakefield’s definition aligns closely with that of the DSM-5 wherein disorder is proposed as 
caused by dysfunction in the psychological, biological or developmental processes that 




Despite the importance of the clinician’s ability to listen for the context in which the patient 
presents their symptoms, valid and reliable symptom measures can be useful tools to inform 
decision making and are vital for research. Measures such as the PHQ-9 (Kroenke et al., 
2001) and the General Health Questionnaire-12 (GHQ-12) (Goldberg and Williams, 1988) 
are one-dimensional measures of symptoms. When used for determining probable caseness, 
they reflect the broad continuum view, with high scores representing the possible presence of 
psychiatric disorder. If one takes the view that a distinction is important (as in the DSM-5), 
recommended cut points on one-dimensional measures do not delineate symptoms which 
may differ systematically (see DSM-5, p.161) depending on whether they are occurring as 
reactions to stressors or dysfunctioning internal systems e.g. pervasive negative beliefs (Beck 
et al., 1979). Although self-report measures will always have limitations, moving beyond 
one-dimensional to multidimensional measures might speed the identification of symptoms 
reflecting possible psychiatric disorder as opposed to general distress reactions. Once 
distinguished, causes of the symptoms may be more directly targeted and care varied 
appropriately.  
 
The Four-Dimensional Symptom Questionnaire  
The Four Dimensional Symptom Questionnaire (4DSQ) was developed in primary care by 
Terluin et al. (2006) to measure general distress, depression, anxiety and somatisation as four 
distinct but related dimensions. Terluin et al. (2006) propose that general distress comprises 
symptoms including feeling down, worry, irritability, poor concentration and sleep problems. 
They conceptualise distress as the manifestation of symptoms in direct response attempting to 
maintain homeostasis in the presence of demanding life stressors (which can be anything that 
poses a threat to such bio-psycho-social homeostasis (Terluin et al., 2006)). Depression, 
however, is conceptualised as reflecting a dysfunction of emotional regulation (Terluin et al., 
2006). Although likely to include all those symptoms indicating distress, depression may be 
identified by additional symptoms that are likely to reflect the presence of dysfunction in 
underlying mental processes. Anhedonia, the inability to experience pleasure, may be a key 
distinguishing factor alongside thoughts of self-harm/suicide and pervasive negative thoughts 
of the self. For anxiety disorders, key distinguishing factors beyond distress may be free 
floating anxiety, irrational fears and avoidance behaviour (Terluin et al., 2014). We will refer 
to distress/disorder distinctions for simplicity throughout this paper, however distress will 
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share a great deal of overlap with depression (Terluin et al., 2006) such that a patient reaching 
caseness for depression would very likely also experience heightened distress. Importantly, 
the reverse may not be the case, and this conceptualisation uniquely allows for identification 
of distressed patients who are not depressed.  
 
There are key differences between the idea of distress/depressive disorder distinctions and the 
conceptualisation underlying the 4DSQ, and notions of ‘reactive’ and ‘endogenous’ 
depression (Parker, 2000).  At first the two appear similar; distress comparable to reactive 
depression as a response to life stressors, and the presented view of depression comparable to 
endogenous depression, being driven by underlying dysfunction in internal systems. 
Critically, in this paper we are not seeking to classify ‘distress’ as a psychiatric disorder, thus 
these reactive and endogenous classifications could still be extrapolated and explored within 
our ‘depression’ category, although they would not apply to distress.  
 
The view of common psychological symptoms underlying the 4DSQ bears close resemblance 
to the tripartite model of depression and anxiety (Clark and Watson, 1991). The tripartite 
model was used to explain the highly correlated relationship between scores on depression 
and anxiety scales (Joiner and Lonigan, 2000), and the three-factor solution that was often 
found to be the best fit for depression and anxiety data. The three factors were proposed as 
representing a non-specific general distress factor, thought to be present in both depression 
and anxiety, then specific factors pertaining to each disorder respectively (Clark and Watson, 
1991).  Key to distinguishing depression from the non-specific distress factor and anxiety 
were low levels of positive affect (PA), corresponding to Terluin et al’s conceptualisation for 
their measure. However, an important difference is that Terluin et al. suggest general distress 
often represents a non-disordered reaction to life stressors. Clark and Watson (1991) 
suggested that scores on depression and anxiety measures that load predominately on the 
general distress factor might indicate ‘General Distress Disorder’. General Distress Disorder 
did not take hold, Clark and Watson (1991) failed to provide a rationale as to why these 
symptoms would constitute a ‘disorder’, and if pursued they likely would have faced calls of 
medicalisation (Mulder, 2008). 
 
The present study 
The present study was designed to explore the symptom profiles of primary care attenders 
when provided with a multidimensional measure with a distinct distress factor, the 4DSQ, 
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compared with measures including the PHQ-9 (Kroenke et al., 2001), the GHQ-12 (Goldberg 
and Williams, 1988) and the Hospital Anxiety and Depression Scale (HADS) (Zigmond and 
Snaith, 1983). We used a ‘consecutive attender’ design, where primary care patients are 
provided with questionnaires in the waiting room before they see their GP. This allowed us to 
compare our results to previous research using this methodology. For instance, Kessler et al. 
(1999) conducted a study utilising a consecutive attender design using the one-dimensional 
GHQ-12, and showed that around 50% of patients attending general clinics had scores 
reflecting possible psychiatric disorder. This finding was challenged as an example of how 
using severity measures like the GHQ-12 can medicalise distress (Heath, 1999).  
 
We aimed to describe the symptoms of patients focusing on the 4DSQ dimensions of distress 
and depression. We also aimed to explore the distress-depression profiles on the 4DSQ of 
those who were classed as ‘cases’ of depression on the traditional measures. We chose not to 





Patients were recruited from general clinics in six primary care practices in the south of 
England. Eligibility criteria were kept as broad as possible, patients had to be over 18 years 
and be able to understand written English to take part. The sample size was determined 
pragmatically, aiming for the highest number of patients feasible within the resource 
constraints of the project. 
 
Measures 
The Four Dimensional Symptom Questionnaire (4DSQ) 
The 4DSQ (Terluin et al., 2006) comprises four subscales measuring distress (16 items), 
depression (6 items), anxiety (12 items) and somatisation (16 items). Respondents rate the 
extent to which they have experienced the listed symptoms/thoughts/feelings over the last 
seven day using five response options: ‘no’, ‘sometimes’, ‘regularly’, ‘often’, ‘very often or 
constantly’. Scorings are 0 for ‘no’, 1 for ‘sometimes’, and 2 for the remaining response 
options. The 4DSQ depression and anxiety sub-scales have strong criterion validity with 
structured diagnostic interviews for depression and anxiety (Terluin et al., 2006), and show 
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convergent validity with measures including the HADS (Terluin et al., 2009). The distress 
subscale represents a unique conceptualisation, nonetheless, Terluin et al. (2006) showed it 
had good criterion validity with GP recording of any psycho-social diagnosis or reason for 
consultation by GPs in a large consecutive attender study. Additionally, the distress subscale 
has shown significant associations with life events, psychosocial problems, work stress, and 
social dysfunctioning (Terluin et al., 2009). Originally developed in Dutch and translated into 
English, a recent study demonstrated that separately, each of the English 4DSQ subscales 
appeared to measure the same constructs as the Dutch subscales in a Canadian sample 
(Cronbach’s alpha for the scales ranged from .85-.92) (Terluin et al., 2014).   
 
The Patient Health Questionnaire-9 (PHQ-9) 
The PHQ-9 is a nine-item scale that corresponds directly to the DSM IV criteria for Major 
Depressive Disorder. Participants answer items regarding depressive symptoms on a four-
point scale ranging from 0 (not at all) to 3 (nearly everyday). The PHQ-9 has strong 
convergent validity with measures such as the Beck Depression Inventory (Dum at al., and 
internal reliability ranging from .86-.89 (Kroenke et al., 2001). 
 
The General Health Questionnaire-12 (GHQ-12) 
The GHQ-12 is a 12-item questionnaire measuring a range of symptoms associated with 
psychiatric disorder (Goldberg and Williams, 1988). It asks if symptoms have been present in 
recent weeks with responses ranging from much more than usual (3) to not at all (0), and has 
been used to detect possible disorder in primary care (Kessler et al., 1999). Reported validity 
coefficients for the GHQ-12 are high (Goldberg et al., 1997). We scored the GHQ-12 
dichotomously (0 1 2 3 became 0 0 1 1).     
 
The Hospital Anxiety and Depression Questionnaire (HADS) 
The HADS measures depression and anxiety on two 7-item subscales (Zigmond and Snaith, 
1983). It focuses particularly on the cognitive components of depression and anxiety, as it 
was developed for use in hospital settings. Participants are asked to rate how they have felt 
over the last week and responses range from 0 to 3. Despite broad use and reports of 
reliability (Bjelland et al., 2002), some have now called for its use to be stopped, due to 
reports of inconsistent factor structures across studies and problems with confusing item 
wordings (Coyne and van Sonderen, 2012).   
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Study research assistants visited the waiting rooms of participating practices over 63 days 
between January 2013 and April 2014. Patients were informed of the study through letters 
sent to those who had appointments on a study day or by posters displayed in the practice. As 
stipulated by the NHS Ethics Committee, to avoid coercion, patients who wanted to take part 
approached the study team and completed a questionnaire pack.  
 
Ethics 




Data were analysed in Stata v12.1 using descriptive statistics.  A total score was calculated 
for each of the key measures by adding up the scores on the component questions according 
to the scoring rubric recommended for each scale.  These scales, and their proposed cut-
points, are based upon each participant completing all the component questions.  Where this 
was not the case and items were skipped, the participant’s total score has been scaled up. For 
example, a participant who skipped 2 items on the PHQ-9 and scored 10 out of 21 would 
have had their score increased to 12.86 out of 27.  Due to the skewed nature of the data, 
means and standard deviations are presented alongside medians and interquartile ranges and 




The sample comprised 487 patients. Participants were predominantly older, female and 
retired. The sample was almost exclusively white. The sample characteristics are reported in 





The 4DSQ subscales  
First we broadly examined the patients’ scores on the scales to determine the average level of 
symptoms of our sample. The mean and medians for each 4DSQ subscale and the additional 
one-dimensional measures are reported below in Table 2. Scores indicate that the majority of 
the sample population were not suffering from any psychological symptoms that might reach 
caseness or higher levels of severity (see table below). The skewed nature of the data is to be 
expected in general waiting room studies with an unselected sample.  
 
 
4DSQ Correlations with other scales 
We examined the correlations of one-dimensional scales (including the PHQ-9 etc.) and the 
4DSQ subscales in order to explore the relationships between the measures. Since the 4DSQ 
purports to measure similar constructs to other validated scales, we would expect a high level 
of correlation.  Given the skew in the data, both the Pearson and Spearman correlation 
coefficients have been calculated.  Both give similar results.  The existing scales were all 
significantly positively correlated with the 4DSQ dimensions at the 5% level. They all tended 





Classification of caseness  
Next we aimed to determine how the measures, with their different conceptualisation of 
symptoms, classified patients as possible cases of psychiatric disorder. As the 4DSQ-distress 
subscale does not have a gold standard comparator to determine cut points, Terluin et al. 
(2006) determined a score with acceptable sensitivity and specificity to detect any 
psychological reason for consultation from GP consultation records (≥11). However, 
percentages presented in Table 4 below are best viewed as those patients with heightened 
distress, rather than a ‘case’ of distress; we do not conceptualise distress as a disorder. Cut 
points for 4DSQ depression caseness (≥6) along with caseness on the PHQ-9 (≥10), GHQ-12 
(≥3) and the HADS-D (≥8) have all been determined by comparison to structured diagnostic 
interviews. Whilst the scales are all correlated, the scores suggest a lack of agreement 
regarding possible caseness for disorder.  A larger proportion of patients are classified as 
depressed by the PHQ-9, GHQ-12 and HADS-D than by the 4DSQ-depression subscale. 
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Similar proportions of patients were identified by the 4DSQ as having heightened symptoms, 
but their scores were more likely to reflect distress than depression, where possible caseness 
was identified in 8% of this sample.  
 
We then examined only those patients in our sample who were classified cases by the widely 
used measures. We wished to observe how the symptoms profile of those patients who were 
meeting caseness on one-dimensional measures would be described by the 4DSQ. It is 
apparent that distress is an element of what the other scales are identifying when they classify 
individuals as cases of possible psychiatric disorder.  Table 5 below shows how those 
classified as cases of possible depression would be classified by the 4DSQ. The pattern that 
repeats throughout all the scales is that the 4DSQ distress subscale corresponds very highly to 
the conceptualisation of depression according to the other measures. However, there is much 
less agreement when focusing on core depression features measured by the 4DSQ-subscale, 
such as anhedonia and thoughts of self-harm. 
 
Finally, as the PHQ-9 is based directly on the DSM IV criteria for major depression, we used 
this scale specifically to look at patients’ scores on both the depression and distress subscales 
and how this compared to casesness for depression as measured by the PHQ-9. Table 6 below 
shows the relationship between casesness on this the PHQ-9 and both the distress and 
depression subscales of the 4DSQ. There are a small number of patients who are scoring as 
cases on the PHQ-9, who do not have high distress scores or are cases of depression on the 
4DSQ. This may be due to the somatic items on the PHQ-9 (e.g. tiredness) that would not be 
picked up by these particular 4DSQ subscales. There a number of patients (33/72, 45.8%) 
who are being classed as cases of depressive disorder by the PHQ-9, who have heightened 




In this study we have shown that the psychological symptom profiles of unselected primary 
care patients attending general clinics change substantially if provided with a measure that 
has distinct distress and depression dimensions. Partialling out non-specific distress and 
focusing on core features of depressive disorder (such as adhedonia and thoughts of self-




with 26% scoring as having heightened general distress. We also showed that by reappraising 
in this way how depression is conceptualised, just under half (46%) of patients in our sample 
who were classified as cases of depressive disorder by the PHQ-9, would be identified as 
experiencing heightened distress, but not showing core depressive disorder symptoms by the 
4DSQ.  
 
It may be best to see both the continuum and distinction conceptualisations as differing but 
valid ways of seeing psychological symptoms. Determining if depression and distress 
symptoms are distinct statistically is likely to be difficult, with factor analytic results often 
varying depending on the assumptions made and the specific modeling techniques used. This 
has been the case with both the HADS (see Cosco et al., 2012) and the GHQ-12 (see Ye et 
al., 2009), with many different factor structures proposed by different authors for the same 
scales.  Nonetheless, we see value in explicitly highlighting the distinction view of symptoms 
as threefold: 1) it is theoretically coherent with regard to defining ‘disorder’, 2) it aligns 
closely with the view expressed within the DSM 5, and 3) it may help develop novel 
stratified or targeted care approaches for patients with different symptom presentations in 
primary care. Parker (2000, 2005) suggests that, despite perhaps increasing simplicity and 
reliability, a unitary approach to symptoms has lead to stagnation in the development of new 
interventions. An additional issue with a broad unitary continuum approach to defining 
disorder that does not account for context and pays less attention to causal processes, is that it 
is likely to lead to mismatches with clinician’s diagnoses. GPs are able to use their clinical 
judgement to take account of the contextual factors and diagnose, or not, accordingly. This is 
one possible interpretation of studies consistently showing the under-detection of disorder 
defined in this way by clinicians (Kessler et al., 1999; Mitchell et al., 2009; Mitchell et al., 
2011). 
 
Due to the inherent complexity in this area, self-report measures can only offer reasonably 
limited descriptions of patient’s experience. Nonetheless, with renewed work on theories of 
mental health states and improvements to the tools we use to measure them, it may be 
possible to ensure the measures we use have high levels of content validity and the potential 
to improve patient care. The 4SDQ represents a useful starting example. Adding a distress 
dimension refines the measurement of depression to its core symptomatology. This 
characteristic may help reduce potential over-classification of depressive disorder that can 
occur with one-dimensional scales. It may also allow for the more rapid identification of 
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patients for whom treatments developed for depressive disorder may be more effective. For 
those patients who are seeking help for heightened distress without core depression features, 
it may open new avenues for intervention and support by avoiding being mislabeled as 
depressed.  
 
With regard to interventions, the distinction view of symptoms may allow us to work toward 
developing novel and effective self-management programmes, designed specifically for 
general distress. The current approach to care for psychological symptoms in general practice 
could be viewed as taking treatments developed for severe disorder and applying them to 
substantial proportions of patients falling along what is seen as a continuum. This is the case 
for both antidepressants and Cognitive Behavioural Therapy (CBT). However, the evidence 
suggests that antidepressants are only effective beyond the placebo response in the most 
severe (Kirsch, 2008; Kirsch et al., 2008; Moncrieff, 2009), and dropout from ‘low intensity’ 
CBT interventions is consistently high (Eysenbach, 2005; Geraghty et al. 2010; Geraghty et 
al. 2013).  These findings may in part stem from the heterogeneity of patients classified as 
depressed using the current broad continuum conceptualisation. Developing specific 
interventions for distress to target the potentially large subgroup of patients who experience 
distress without reaching caseness for depressive disorder, may increase the efficacy of, and 
engagement with, interventions in this subgroup. Traditional treatments such as 
antidepressants and CBT, both designed to address dysfunctioning internal systems, whether 
biological, cognitive or affective may be less effective for patients experiencing non-
disordered distress.  
 
Future trials to evaluate the effect of applying this distinction to service delivery might 
investigate stratified care based on symptom presentation. For instance, a distinct care 
pathway could be developed for those patients who present to primary care experiencing 
heightened distress without core depression symptoms, and where the clinician assesses the 
key driver of the symptoms to be external stressors. Developed with extensive qualitative 
work with patients, this pathway may involve educational components about the nature and 
function of distress, and techniques regarding how to manage difficult emotions in the 
context of crisis or chronic stressors. The rationales in such a pathway would differ from 
education about, and subsequent treatment for depression where causes may be attributed 
primarily to dysfunctional cognitive schemas, or behaviors of the patient. A key test would to 
be to show that stratifying patients to treatment pathways based on distress/depression 
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distinctions would lead to greater patient well-being and satisfaction than the current 
continuum approach, where all patients will be treated as having a depressive disorder when 
they reach a particular threshold of severity and functional disability.  
 
Both qualitative and quantitative methodologies are important in continuing to explore this 
area. Qualitative research with patients is necessary to ensure conceptual/quantitative 
exportations of these issues map on to patients’ experiences and perceptions of their mental 
health symptoms. Triangulation of quantitative and quantitative data will support the 
development of measures and educational rationales that are acceptable to patients. 
Qualitative work with GPs is also necessary. GPs may draw upon differing models when 
assessing and treating patients with mental health problems. In depth qualitative studies will 
enable us to determine if GPs are already applying this distinction, or what issues they 
foresee in its application to day-to-day practice.  If trials and future studies show that 
investigation of a distinction and application in practice improves mental health care, as 
context and clinical judgement are important, training for GPs may be necessary to reduce 
variability in assessment. Future quantitative work could include the 4DSQ in depression 
trials to explore whether the distress and depression subscales have predictive validity in 
regard to outcomes. For instance, are patients identified as cases on the depression scale more 
likely to experience benefit beyond placebo from antidepressants compared to those patients 
with heightened distress without depression? 
 
There are some limitations to be considered with regard to our data. Our sample was 
predominantly older, female and white, thus the 4DSQ and additional scales may perform 
differently in samples with a differing demographic make-up.  The 4DSQ is 50 items long 
which may form a barrier to use. Nevertheless, the Dutch version is used in clinical practice 
within The Netherlands (Terluin et al., 2008), where patients often take the scale with away 
when them and complete it between appointments (comparable for how lab tests are used for 
instance). With future research it may be possible to develop a reduced multidimensional 
scale, suitable for research studies where patient load is an issue. In addition, our 
conceptualisation could perhaps be applied to existing measures, by weighting certain items 
that theoretically are more likely to align with emotional distress or psychiatric disorder. 
Finally, we did not record whether patients in our sample had long-term health conditions 
such as diabetes, asthma or COPD. Exploring the distinction conceptualisation in patients 
with multimorbid health conditions may present a fruitful avenue for research. Tools to help 
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determine whether patient’s psychological symptoms are primarily a distress reaction driven 
by their physical condition, or a reflection of underlying psychiatric dysfunction may 
facilitate the targeting of appropriate treatment.  
To conclude, we are primarily interested in the clinical utility of viewing emotional distress 
and psychiatric disorder as related but distinct constructs. Research is needed to determine if 
this view of a distinction aligns with patients’ phenomenological experiences’, and work is 
required to develop and evaluate distress-specific interventions for (self-) management. 
Broadening both conceptual and intervention approaches, by acknowledging the full diversity 
of psychological problems presented in general practice, may enable GPs to support the 
mental health of their patients more effectively. 
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Table 1. Demographic characteristics of the sample 
 Demographic characteristic Proportion 
Female 294/487 (60.37%) 















White ethnicity 473/485 (97.53%) 
Age left education 18.46 (3.18) 
Employment status  
Full time employee 
Part time employee 
Self employed (full time) 
Self employed (partime) 
Homemaker 
Retired 
Not in employment due to 
disability 
Not in employment due to 





























Note. 4DSQ: Four-Dimensional Symptom Questionnaire. PHQ-9: Patient Health 
Questionnaire-9. GHQ-12: General Health Questionnaire-12. HADS: Hospital Anxiety 
and Depression Scale.  
 
Measure (possible range) Mean (SD) Median (IQR) 
      Distress (0-32) 7.62 (7.58) 5 (2,11) 
Depression (0-12) 1.15 (2.51)  0 (0,1) 
Anxiety (0-24) 1.94 (3.95)  0 (0,2) 
Somatization (0-32) 6.35 (6.21)  5 (2,8.5) 
PHQ-9 (0-27) 4.91 (5.75) 3 (1,7) 
GHQ-12 (0-12) 2.20 (3.43) 0 (0,3) 
HADS-D (0-21) 3.75 (3.77) 3 (1,6) 
Table(s)
Table 3. Spearman and Person’s correlations between the scales  
Note. 4DSQ: Four-Dimensional Symptom Questionnaire. PHQ-9: Patient Health 
Questionnaire-9. GHQ-12: General Health Questionnaire-12. HADS: Hospital Anxiety and 
Depression Scale.  
 
4DSQ PHQ-9 HADS-D GHQ-12 
 Spearman Pearson Spearman Pearson Spearman Pearson 
Distress 0.8273 0.8579 0.6821 0.7702 0.7254 0.8054 
Depression 0.5845 0.7166 0.6246 0.6992 0.6514 0.6999 
Table(s)
Table 4. Cut points and the number (%) of patients classed as a case on each scale 
Note. 4DSQ: Four-Dimensional Symptom Questionnaire. PHQ-9: Patient Health 
Questionnaire-9. GHQ-12: General Health Questionnaire-12. HADS: Hospital Anxiety 
and Depression Scale.  
 
Scale Cut point used (≥) Number classed as a case (%) 
4DSQ – distress 11 126/485(25.98%) 
4DSQ – depression 6 38/468 (8.12%) 
PHQ – 9   10 78/479 (16.28%) 
PHQ – 9   5 176/479 (36.74%) 
GHQ-12  3 131/457 (28.67%) 
HADS-D 8 64/464 (13.79%) 
Table(s)
Table 5.  4DSQ distress and depression profiles of patients scoring as cases on the PHQ-9, 











Note. 4DSQ: Four-Dimensional Symptom Questionnaire. PHQ-9: Patient Health 
Questionnaire-9. GHQ-12: General Health Questionnaire-12. HADS: Hospital Anxiety 
and Depression Scale.  
 
Case on scale: Proportion classed 
as distressed on the 
4DSQ 
Proportion classed as 
depressed on the 
4DSQ 
PHQ – 9   
(using cut point of 10) 
71/78 (91.03%)   32/72 (44.44%) 
PHQ – 9   
(using cut point of 5) 
111/176 (63.07%) 38/167 (22.75%) 
HADS-D 49/63 (77.78%) 29/58 (50.00%) 
GHQ-12  92/131 (70.77%) 33/131 (26.61%) 
Table(s)
Table 6.  Classification table showing 4SDQ distress and depression ‘casness’ in 
comparison with the PHQ-9 (≥10) 
Note. 4DSQ: Four-Dimensional Symptom Questionnaire. PHQ-9: Patient Health 
Questionnaire-9.  
 
4DSQ 4DSQ PHQ-9 –  PHQ-9 +  Total 
distress - dep - 337 7 344 
dep + 0 0 0 
distress + dep - 46 33 79 
dep + 6 32 38 
Total   389 72 461 
Table(s)
